Top in endocrinology: Type 1 diabetes and COVID-19, specialist gender clinics

An analysis of hospital data showed that type 1 diabetes does not increase the risk for hospitalization from COVID-19. It was the top story in endocrinology last week.

Another top story was about a study that showed referrals for transgender and gender-diverse children to specialist gender clinics increase with media coverage on transgender topics.

Read these and more top stories in endocrinology below:

No association between type 1 diabetes status, COVID-19 hospitalization risk

Type 1 diabetes does not increase risk for hospitalization from COVID-19, particularly among individuals without diabetes complications, according to an analysis of hospital data. Read more.

Pediatric referrals to specialist gender clinics increase with media coverage

Referrals for transgender and gender-diverse children to specialist gender clinics in the United Kingdom and Australia increased with media coverage on transgender topics, according to study data published in JAMA Network Open. Read more.

Common and unrecognized, primary aldosteronism warrants more screening, targeted treatment

Primary aldosteronism, an adrenal disorder and a secondary cause of hypertension, has historically been considered a rare condition. New research may change that thinking. Read more.

Skin care essential to preventing infections while using diabetes devices

Good skin care and proper use of wearable diabetes technology can help prevent skin issues related to insulin pump or continuous glucose monitor use, according to two speakers at the Association of Diabetes Care and Education Specialists Annual Meeting. Read more.

Survey reveals how hypoglycemia is referred to, treated in real world

People with diabetes reported identifying and treating “low” and “hypo” at relatively high blood glucose levels, and that symptoms of hypoglycemia changed over time, according to survey results. Read more.